← Browse by Condition
Medical Condition

clinical high risk for psychosis chr

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT07226895 Phase 1, Phase 2
Recruiting

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

Enrollment
150 pts
Location
United States
Sponsor
Monument Therapeutics Limited
View Trial →